Recent Developments in Drug Delivery for Treatment of Tuberculosis by Targeting Macrophages (Adv. Therap. 6/2022)

Recent Developments in Drug Delivery for Treatment of Tuberculosis by Targeting Macrophages (Adv. Therap. 6/2022)

Macrophages are a known reservoir for Mycobacterium tuberculosis. Drug delivery to macrophages is an efficient approach to improve tuberculosis therapy. Nanocarriers decorated with macrophage specific ligands can increase the efficacy of antibiotics. This is reported by Jeffrey D. Cirillo, Hung‐Jen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Advanced therapeutics 2022-06, Vol.5 (6), p.n/a
Hauptverfasser: Gairola, Anirudh, Benjamin, Aaron, Weatherston, Joshua D., Cirillo, Jeffrey D., Wu, Hung‐Jen
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Macrophages are a known reservoir for Mycobacterium tuberculosis. Drug delivery to macrophages is an efficient approach to improve tuberculosis therapy. Nanocarriers decorated with macrophage specific ligands can increase the efficacy of antibiotics. This is reported by Jeffrey D. Cirillo, Hung‐Jen Wu, and co‐workers in article number 2100193.
ISSN:2366-3987
2366-3987
DOI:10.1002/adtp.202270011